Infasurf from ONY Biotech.

First breath. First steps. First day of school. Since Infasurf’s FDA approval in 1998, ONY Biotech has made tomorrow possible for so many premature babies and their families, thanks to Infasurf®.

ONY Biotech’s primary commercial product, Infasurf®, helps prevent and treat respiratory distress syndrome in newborns, restoring surface activity in the lungs and quickly improving respiration.

View Prescribing Information